Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | NXC-201 |
Trade Name | |
Synonyms | NXC201|NXC 201|HBI0101|HBI-0101|HBI 0101 |
Drug Descriptions |
NXC-201 is a chimeric antigen receptor (CAR)-T cell therapy targeting TNFRSF17 (BCMA), which potentially decreases tumor growth (PMID: 38768428). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C205068 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
NXC-201 | NXC-201 | 0 | 1 |